Characterization of tenofovir-induced mitochondrial dysfunction in renal cells

被引：0
|
作者：
Milian-Medina, L. [1 ,2 ]
Blas-Garcia, A. [1 ,2 ]
Esplugues, J. V. [1 ,2 ,3 ]
Pallardo, L. [4 ]
Peris, J. E. [5 ]
Gorriz, J. L. [4 ]
机构：
[1] Univ Valencia, Fac Med, Dept Farmacol, Valencia, Spain
[2] FISABIO Fdn El Fomento Invest Sanit & Biomed Comu, Valencia, Spain
[3] CIBERehd, Valencia, Spain
[4] Hosp Univ Dr Peset, Serv Nefrol, Valencia, Spain
[5] Univ Valencia, Fac Farm, Dept Farm & Tecnol Farmaceut, E-46010 Valencia, Spain
来源：
ANTIVIRAL THERAPY | 2014年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
P28
引用
收藏
页码：A49 / A49
页数：1
相关论文
共 50 条
  • [21] Rosiglitazone reverses tenofovir-induced nephrotoxicity
    Liborio, Alexandre B.
    Andrade, Lucia
    Pereira, Leonardo V. B.
    Sanches, Talita R. C.
    Shimizu, Maria H.
    Seguro, Antonio C.
    KIDNEY INTERNATIONAL, 2008, 74 (07) : 910 - 918
  • [22] MITOCHONDRIAL DYSFUNCTION INDUCED BY TENOFOVIR IN RENAL CELLS. POTENTIATION OF THE EFFECTS BY CO-STIMULATION WITH ANGIOTENSIN II
    Milian, Lara
    Blas-Garcia, Ana
    Polo, Miriam
    Vicente Esplugues, Juan
    Pallardo, Luis M.
    Peris, Jose E.
    Castro, Cristina
    Luis Gorriz, Jose
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [23] Early onset of tenofovir-induced renal failure: Case report and review of the literature
    Patel, Shilpa M.
    Zembower, Teresa R.
    Palella, Frank
    Kanwar, Yashpal S.
    Ahya, Shubhada N.
    THESCIENTIFICWORLDJOURNAL, 2007, 7 : 1140 - 1148
  • [24] Clinical and pharmacogenetic determinants of tenofovir-induced renal toxicity in HIV positive patients in Zambia
    Hamachila, Audrey
    Pushpakom, Sudeep
    Jorgensen, Andrea
    Pirmohamed, Munir
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (12) : 4889 - 4889
  • [25] Tenofovir-induced distal renal tubular acidosis: A rare cause of recurrent hypokalaemic paralysis
    Dave, Mahesh
    Sareen, Manasvin
    Goyal, Anuj
    Gonchikar, Nagaraj T.
    Shah, Yash
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2022, 52 (02): : 117 - 119
  • [26] TENOFOVIR-INDUCED TYPE II RENAL TUBULAR ACIDOSIS AND FANCONI SYNDROME: A CASE REPORT
    Saeed, Mariam
    Khan, Muneer
    Nalamati, Jhansi
    CHEST, 2019, 156 (04) : 1938A - 1938A
  • [27] Treatment with β-blocker nebivolol ameliorates oxidative stress and endothelial dysfunction in tenofovir-induced nephrotoxicity in rats
    Nascimento, Mariana Moura
    Bernardo, Desiree Rita Denelle
    de Braganca, Ana Carolina
    Massola Shimizu, Maria Heloisa
    Seguro, Antonio Carlos
    Volpini, Rildo Aparecido
    Canale, Daniele
    FRONTIERS IN MEDICINE, 2022, 9
  • [28] Role of reactive oxygen species (ROS) and TGF-β in tenofovir-induced renal tubular toxicity
    Cotter, E. J.
    Feeney, E. R.
    Mallon, P. W.
    Murray, P. T.
    Powderly, W. G.
    Doran, P. P.
    ANTIVIRAL THERAPY, 2010, 15 : A19 - A20
  • [29] Tenofovir-induced tetraparesis related to severe hypokalemia and rhabdomyolisis
    Menna-Barreto, M.
    Olson, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 120 - 120
  • [30] Role of reactive oxygen species (ROS) and TGF-β in tenofovir-induced renal tubular toxicity
    Cotter, E. J.
    Feeney, E. R.
    Mallon, P. W.
    Murray, P. T.
    Powderly, W. G.
    Doran, P. P.
    ANTIVIRAL THERAPY, 2010, 15 (08) : A19 - A20
12345